BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
FGF21
,
calcium channel activity
,
Allergy to pollen
,
Breast
,
Phenobarbital
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
p90RSK
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Neutrophil of bone marrow
Whole blood
Microglial cell
Eosinophil of peripheral blood
Leukocyte (polymorphonuclear) of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
RSK1 SUMOylation is required for KSHV lytic replication.
Targeting EGFR, RSK1, RAF1, PARP2 and LIN28B for several cancer type therapies with newly synthesize…
ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 …
Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer.
The Preeclamptic Environment Promotes the Activation of Transcription Factor Kappa B by P53/RSK1 Com…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer
Safety and Preliminary Efficacy of ATG-017 Monotherapy in Advanced Solid Tumors and Hematological Ma…
2157GCCC:Phase 1 of Calaspargase Pegol-mknl w/ Cytarabine and Idarubicin in Newly Dx AML
A First-in-human Study of the Safety, Tolerability, and PK of XFB-19 in Healthy Adult Volunteers
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ